NASCENT BIOTECH
Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic antibodies. The innate ability of the intelligence of the natural human immune system to generate a cancer-specific response combined with NBI’s technical skills opens the door for immunologically based therapeutics for human cancer. NBI is using and developing human antibodies and cytokine responses obtained from the innate natural human immune response as a drug discovery platform for identifying new an... tibodies and antigens for commercialization. Nascent Biotech's technology portfolio is based upon the natural human immune system, uniquely utilizing the immune system’s innate capabilities and selectivity to produce effective immune-boosting and regulation biomolecules. Their insight into the natural human immune response defines important targets for therapeutic intervention thus enabling the rapid development of new classes of safe, non-toxic, and specific biological drugs for use in the clinic.
NASCENT BIOTECH
Industry:
Biotechnology Health Care Innovation Management Therapeutics
Founded:
2008-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.nascentbiotech.com
Total Employee:
1+
Status:
Active
Contact:
858-566-9490
Total Funding:
3.18 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
AYOXXA
AYOXXA is a biotech company commercializing innovative technology.
BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
Centre for Innovation in Regulatory Science
Centre for Innovation in Regulatory Science is provides an international forum for industryand other healthcare stakeholders to meet, debate
Genencor International
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of DuPont.
Grove Biopharma
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Hongyun Biotech
Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.
Mirexus Biotechnologies
Mirexus Inc. is a start-up company which is commercializing a novel “green” technology based on polysaccharide sub-micron particles that
Novozymes
Novozymes is the world leader in bioinnovation.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Restore Vision
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Employees Featured
Onur Boyman Co-Founder and Director @ Nascent Biotech
Co-Founder and Director
Jonathan Sprent Co-Founder and Director @ Nascent Biotech
Co-Founder and Director
Mark C. Glassy Co-Founder @ Nascent Biotech
Co-Founder
Founder
Stock Details
Investors List
BioRay Pharmaceutical
BioRay Pharmaceutical investment in Grant - Nascent Biotech
BioRay Pharmaceutical
BioRay Pharmaceutical investment in Grant - Nascent Biotech
Official Site Inspections
http://www.nascentbiotech.com
- Host name: vps35231.servconfig.com
- IP address: 209.182.193.252
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Nascent Biotech"
Nascent Biotech, home of human antibody cancer product …
Feb 6, 2024 · Nascent Biotech is the home of the natural human antibody cancer product Pritimumab, which has been shown to fight rare forms of cancer successfully.See details»
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Aug 22, 2023 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Biotech, Inc. (NBIO) Company Profile & Facts - Yahoo …
See the company profile for Nascent Biotech, Inc. (NBIO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Nascent Biotech - Crunchbase Company Profile & Funding
View contacts for Nascent Biotech to access new leads and connect with decision-makers. Nascent Biotech is a biotechnology company building a portfolio of innovative therapeutic …See details»
Nascent Biotech, Inc. - Company Profile & Staff Directory
Nascent Biotech, Inc. (OTCMKTS:NBIO) is a public company, formed in March 2014, to continue development of Pritumumab, a human monoclonal antibody created by a number of leading …See details»
Nascent Biotech, Inc. (NBIO) Company Profile & Overview - Stock …
Nov 15, 2024 · Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer.See details»
Nascent Begins Enrollment of Final Patient Cohort to Complete …
Oct 4, 2022 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers and …See details»
Nascent Biotech - Changing the Biotechnology Industry - Yahoo …
Aug 28, 2022 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various …See details»
Nascent Biotech Commencing Enrollment of Second Cohort in …
Jun 8, 2021 · Nascent Biotech, Inc. (OTCQB: NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various …See details»
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Aug 22, 2023 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Biotech Inc - Overview, News & Similar companies
Aug 28, 2022 · Nascent Biotech Inc contact info: Phone number: (612) 961-5656 Website: www.nascentbiotech.com What does Nascent Biotech Inc do? Nascent Biotech is a clinical …See details»
Nascent Biotech Receives Full IND Clearance to Begin Phase I …
SAN DIEGO, CA / ACCESSWIRE / December 15, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) On December 7, the Company received a letter from the US Food and Drug Administration …See details»
Nascent Biotech Regains Worldwide Rights for Pritumumab
May 26, 2023 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Prepares for Pivotal Phase II Research with ... - Nascent …
Apr 16, 2024 · Nascent Biotech, Inc. (OTCQB:NBIO) is a phase 2 clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Collaborates With Hypospray Pharma on Proprietary
Mar 19, 2024 · Nascent Biotech, Inc. (OTCQB:NBIO) is a phase 2 clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Biotech Phase I Clinical Data Presented at the American …
Jun 7, 2023 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of human monoclonal antibodies to be used in the treatment of …See details»
Nascent Biotech to begin Phase 1 Human Trials for Brain
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO) (the “Company” or “Nascent”) is pleased to announce that the Company will soon begin Phase 1 …See details»
Nascent Announces the Completion of Its Phase 1 Clinical Trials
Feb 28, 2023 · Nascent Biotech, Inc. (OTCQB: NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various …See details»
Nascent Biotech Earns US Patent for Crossing Blood-Brain Barrier
Mar 2, 2021 · Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various …See details»
Nascent Biotech and Manhattan BioSolutions Announce Promising …
Jul 13, 2021 · SAN DIEGO, CA / ACCESSWIRE / July 13, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a biotechnology company …See details»